相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Localization of 20-kD homologous restriction factor (HRF20) in diseased human glomeruli. An immunofluorescence study
H. TAMAI et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues
M. ENDOH et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Membrane-bound complement regulatory activity is decreased on vaccinia virus-infected cells
L. BARANYI et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis
D. A. Copland et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Novel aspects of complement in kidney injury
Mark B. Vieyra et al.
KIDNEY INTERNATIONAL (2010)
Complement control protein factor H: The good, the bad, and the inadequate
Viviana P. Ferreira et al.
MOLECULAR IMMUNOLOGY (2010)
Complement in neuroprotection and neurodegeneration
Vijay Yanamadala et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Oxidative Stress Renders Retinal Pigment Epithelial Cells Susceptible to Complement-mediated Injury
Joshua M. Thurman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Regulation of Liver Cell Survival by Complement
Maciej M. Markiewski et al.
JOURNAL OF IMMUNOLOGY (2009)
Recent developments in low molecular weight complement inhibitors
Hongchang Qu et al.
MOLECULAR IMMUNOLOGY (2009)
Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59
Zhonghua Qu et al.
MOLECULAR IMMUNOLOGY (2009)
Primary human hepatocytes are protected against complement by multiple regulators
Jarkko Halme et al.
MOLECULAR IMMUNOLOGY (2009)
Role of DAF in Protecting against T-Cell Autoreactivity that Leads to Experimental Autoimmune Uveitis
Fengqi An et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Immune complex clearance by complement receptor type 1 in SLE
Maria Kavai
AUTOIMMUNITY REVIEWS (2008)
Reduced erythrocyte CR1 levels in patients with pulmonary tuberculosis is an acquired phenomenon
P. Senbagavalli et al.
CLINICAL IMMUNOLOGY (2008)
Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice
Carl Atkinson et al.
JOURNAL OF IMMUNOLOGY (2008)
A Novel Targeted Inhibitor of the Alternative Pathway of Complement and Its Therapeutic Application in Ischemia/Reperfusion Injury
Yuxiang Huang et al.
JOURNAL OF IMMUNOLOGY (2008)
Modulation of the antitumor immune response by complement
Maciej M. Markiewski et al.
NATURE IMMUNOLOGY (2008)
Inherited complement deficiencies and bacterial infections
Francesco Tedesco
VACCINE (2008)
Translational Mini-Review Series on Complement Factor H: Therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis
M. Noris et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
Russell P. Rother et al.
NATURE BIOTECHNOLOGY (2007)
In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab
Paolo Macor et al.
CANCER RESEARCH (2007)
Complement as effector system in cancer immunotherapy
Paolo Macor et al.
IMMUNOLOGY LETTERS (2007)
Human herpesvirus 7 infection increases the expression levels of CD46 and CD59 in target cells
Masaya Takemoto et al.
JOURNAL OF GENERAL VIROLOGY (2007)
The simple design of complement factor H: Looks can be deceiving
Jessy J. Alexander et al.
MOLECULAR IMMUNOLOGY (2007)
Expression of innate immune complement regulators on brain epithelial cells during human bacterial meningitis
Cecile Canova et al.
JOURNAL OF NEUROINFLAMMATION (2006)
Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU)
Purushottam Jha et al.
JOURNAL OF IMMUNOLOGY (2006)
Complement activation in diabetic ketoacidosis brains
William H. Hoffman et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2006)
Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration
B Gold et al.
NATURE GENETICS (2006)
Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis
RW Read et al.
EXPERIMENTAL EYE RESEARCH (2006)
The complement system plays a critical role in the development of experimental autoimmune anterior uveitis
P Jha et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion
JM Thurman et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare
DJ Birmingham et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells
K Elward et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site
TS Jokiranta et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection
C Atkinson et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration
GS Hageman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Decay-accelerating factor modulates induction of T cell immunity
PS Heeger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9
C He et al.
JOURNAL OF IMMUNOLOGY (2005)
CD46: expanding beyond complement regulation
RC Riley-Vargas et al.
TRENDS IN IMMUNOLOGY (2004)
Expression of complement factor H by lung cancer cells:: Effects on the activation of the alternative pathway of complement
D Ajona et al.
CANCER RESEARCH (2004)
Deficiency of the complement regulator CD59a enhances disease severity, demyelination and axonal injury in murine acute experimental allergic encephalomyelitis
RJ Mead et al.
LABORATORY INVESTIGATION (2004)
Down-regulation of CD46 by piliated Neisseria gonorrhoeae
DB Gill et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia /reperfusion damage, acute rejection, and chronic nephropathy
JR Pratt et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid
N Donin et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Interactions of CD55 with non-complement ligands
S Lea
BIOCHEMICAL SOCIETY TRANSACTIONS (2002)
Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury
JC Mason et al.
CIRCULATION RESEARCH (2002)
Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes.: Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies
F Lin et al.
IMMUNOLOGY (2001)
Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59b
XB Qin et al.
MAMMALIAN GENOME (2001)
C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: Implications for systemic autoimmunity
D Gershov et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
